BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 12412029)

  • 41. Magnetic resonance spectroscopy of the thalamus in essential tremor patients.
    Kendi AT; Tan FU; Kendi M; Erdal HH; Tellioglu S
    J Neuroimaging; 2005 Oct; 15(4):362-6. PubMed ID: 16254402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
    Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
    AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proton MR spectroscopic findings in paroxysmal kinesigenic dyskinesia.
    Kim MO; Im JH; Choi CG; Lee MC
    Mov Disord; 1998 May; 13(3):570-5. PubMed ID: 9613757
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Value of 1H-MRS on SCA3/MJD diagnosis and clinical course].
    Xing W; Liao X; Guan T; Xie F; Shen L; Liao W; Wang X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):291-297. PubMed ID: 28364102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proton magnetic resonance spectroscopy of brain-stem lesions.
    Smith JK; Londono A; Castillo M; Kwock L
    Neuroradiology; 2002 Oct; 44(10):825-9. PubMed ID: 12389131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intraindividual variability of striatal (1)H-MRS brain metabolite measurements at 3 T.
    Soreni N; Noseworthy MD; Cormier T; Oakden WK; Bells S; Schachar R
    Magn Reson Imaging; 2006 Feb; 24(2):187-94. PubMed ID: 16455408
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients.
    Gonul AS; Kitis O; Ozan E; Akdeniz F; Eker C; Eker OD; Vahip S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):120-5. PubMed ID: 16236417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
    Zacharia TT; Law M; Naidich TP; Leeds NE
    J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
    Dubey P; Fatemi A; Barker PB; Degaonkar M; Troeger M; Zackowski K; Bastian A; Smith SA; Pomper MG; Moser HW; Raymond GV
    Neurology; 2005 Jan; 64(2):304-10. PubMed ID: 15668429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human brain MR spectroscopy thermometry using metabolite aqueous-solution calibrations.
    Covaciu L; Rubertsson S; Ortiz-Nieto F; Ahlström H; Weis J
    J Magn Reson Imaging; 2010 Apr; 31(4):807-14. PubMed ID: 20373423
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Magnetic resonance spectroscopic evaluation of brain tissue metabolism after irradiation for pediatric brain tumors in long-term survivors: a report of two cases.
    Blamek S; Wydmański J; Sokół M; Matulewicz L; Boguszewicz L
    Acta Neurochir Suppl; 2010; 106():191-4. PubMed ID: 19812947
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative proton magnetic resonance spectroscopy of the cervical spinal cord.
    Cooke FJ; Blamire AM; Manners DN; Styles P; Rajagopalan B
    Magn Reson Med; 2004 Jun; 51(6):1122-8. PubMed ID: 15170831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 1H NMR spectroscopic imaging of the mouse brain at 9.4 T.
    Miyasaka N; Takahashi K; Hetherington HP
    J Magn Reson Imaging; 2006 Oct; 24(4):908-13. PubMed ID: 16958063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 1H-MRS alterations in the cerebellum of patients with familial hemiplegic migraine type 1.
    Dichgans M; Herzog J; Freilinger T; Wilke M; Auer DP
    Neurology; 2005 Feb; 64(4):608-13. PubMed ID: 15728280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 1H metabolite relaxation times at 3.0 tesla: Measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation.
    Träber F; Block W; Lamerichs R; Gieseke J; Schild HH
    J Magn Reson Imaging; 2004 May; 19(5):537-45. PubMed ID: 15112302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reproducibility of hippocampal single-Voxel proton MR spectroscopy and chemical shift imaging.
    Hsu YY; Chen MC; Lim KE; Chang C
    AJR Am J Roentgenol; 2001 Feb; 176(2):529-36. PubMed ID: 11159110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
    Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
    Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proton magnetic resonance spectroscopy (1H-MRS) of the cerebellum in men with schizophrenia.
    Tibbo P; Hanstock CC; Asghar S; Silverstone P; Allen PS
    J Psychiatry Neurosci; 2000 Nov; 25(5):509-12. PubMed ID: 11109301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.